176 related articles for article (PubMed ID: 25044030)
1. Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network.
Ogdie A; Alehashemi S; Love TJ; Jiang Y; Haynes K; Hennessy S; Choi H; Gelfand JM
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):918-22. PubMed ID: 25044030
[TBL] [Abstract][Full Text] [Related]
2. Validity of ankylosing spondylitis diagnoses in The Health Improvement Network.
Dubreuil M; Peloquin C; Zhang Y; Choi HK; Inman RD; Neogi T
Pharmacoepidemiol Drug Saf; 2016 Apr; 25(4):399-404. PubMed ID: 26762622
[TBL] [Abstract][Full Text] [Related]
3. The validity of the diagnosis of inflammatory arthritis in a large population-based primary care database.
Nielen MM; Ursum J; Schellevis FG; Korevaar JC
BMC Fam Pract; 2013 Jun; 14():79. PubMed ID: 24128086
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and treatment patterns of psoriatic arthritis in the UK.
Ogdie A; Langan S; Love T; Haynes K; Shin D; Seminara N; Mehta NN; Troxel A; Choi H; Gelfand JM
Rheumatology (Oxford); 2013 Mar; 52(3):568-75. PubMed ID: 23221331
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data.
Chung CP; Rohan P; Krishnaswami S; McPheeters ML
Vaccine; 2013 Dec; 31 Suppl 10():K41-61. PubMed ID: 24331074
[TBL] [Abstract][Full Text] [Related]
6. Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis.
Walsh JA; Pei S; Penmetsa GK; Sauer BC; Patil V; Walker JH; Clewell J; Douglas KM; Clegg DO; Cannon GW; Halwani A
J Manag Care Spec Pharm; 2019 Nov; 25(11):1218-1228. PubMed ID: 31663467
[TBL] [Abstract][Full Text] [Related]
7. Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009.
Asgari MM; Wu JJ; Gelfand JM; Salman C; Curtis JR; Harrold LR; Herrinton LJ
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):842-9. PubMed ID: 23637091
[TBL] [Abstract][Full Text] [Related]
8. Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database.
Cho SK; Sung YK; Choi CB; Kwon JM; Lee EK; Bae SC
Rheumatol Int; 2013 Dec; 33(12):2985-92. PubMed ID: 23918169
[TBL] [Abstract][Full Text] [Related]
9. Treatment patterns in psoriatic arthritis patients newly initiated on oral nonbiologic or biologic disease-modifying antirheumatic drugs.
Zhang HF; Gauthier G; Hiscock R; Curtis JR
Arthritis Res Ther; 2014 Aug; 16(4):420. PubMed ID: 25146329
[TBL] [Abstract][Full Text] [Related]
10. Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.
Simone D; Nowik M; Gremese E; Ferraccioli GF
J Rheumatol Suppl; 2015 Nov; 93():65-9. PubMed ID: 26523061
[TBL] [Abstract][Full Text] [Related]
11. Identification of rheumatoid arthritis patients using an administrative database: a Veterans Affairs study.
Ng B; Aslam F; Petersen NJ; Yu HJ; Suarez-Almazor ME
Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1490-6. PubMed ID: 22623324
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.
Walsh JA; Gottlieb AB; Hoepken B; Nurminen T; Mease PJ
Clin Rheumatol; 2018 Dec; 37(12):3285-3296. PubMed ID: 30191421
[TBL] [Abstract][Full Text] [Related]
13. First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011: data from the NOR-DMARD register.
Lie E; Fagerli KM; Mikkelsen K; Rødevand E; Lexberg A; Kalstad S; Uhlig T; Kvien TK
Ann Rheum Dis; 2014 Oct; 73(10):1905-6. PubMed ID: 24989896
[No Abstract] [Full Text] [Related]
14. High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs: A cross-sectional study.
Behrens F; Rech J; Thaçi D; Zinke S; Rothnie KJ; Oefner Daamen C; Leipe J
Mod Rheumatol; 2022 Jan; 32(1):87-95. PubMed ID: 32856975
[TBL] [Abstract][Full Text] [Related]
15. Validation of asthma recording in the Clinical Practice Research Datalink (CPRD).
Nissen F; Morales DR; Mullerova H; Smeeth L; Douglas IJ; Quint JK
BMJ Open; 2017 Aug; 7(8):e017474. PubMed ID: 28801439
[TBL] [Abstract][Full Text] [Related]
16. Model to Determine the Cost-Effectiveness of Screening Psoriasis Patients for Psoriatic Arthritis.
Iragorri N; Hazlewood G; Manns B; Bojke L; Spackman E;
Arthritis Care Res (Hoboken); 2021 Feb; 73(2):266-274. PubMed ID: 31733035
[TBL] [Abstract][Full Text] [Related]
17. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
[TBL] [Abstract][Full Text] [Related]
18. Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Codes Are Not Available: A Validation Study Comparing Medication/Prescriber Visit-Based Algorithms with Diagnosis Codes.
Dobson-Belaire W; Goodfield J; Borrelli R; Liu FF; Khan ZM
Value Health; 2018 Jan; 21(1):110-116. PubMed ID: 29304935
[TBL] [Abstract][Full Text] [Related]
19. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
[TBL] [Abstract][Full Text] [Related]
20. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.
Ogdie A; Yu Y; Haynes K; Love TJ; Maliha S; Jiang Y; Troxel AB; Hennessy S; Kimmel SE; Margolis DJ; Choi H; Mehta NN; Gelfand JM
Ann Rheum Dis; 2015 Feb; 74(2):326-32. PubMed ID: 25351522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
